BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Amgen
National Cancer Center Hospital East
University of Washington
Stanford University
Freenome Holdings Inc.
I-Mab Biopharma US Limited
City of Hope Medical Center
City of Hope Medical Center
Elevation Oncology
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
BioMed Valley Discoveries, Inc
Dana-Farber Cancer Institute
NRG Oncology
Abramson Cancer Center at Penn Medicine
Hoffmann-La Roche
University of California, San Francisco
Thomas Jefferson University
Imugene Limited
University of Utah
Boehringer Ingelheim
Wake Forest University Health Sciences
Columbia University
NantBioScience, Inc.
Theseus Pharmaceuticals
Academic and Community Cancer Research United
Kyowa Kirin Co., Ltd.
Five Prime Therapeutics, Inc.
Massachusetts General Hospital
Fengh Medical Co., Ltd.
SCRI Development Innovations, LLC
InnoPharmax Inc.
Sumitomo Pharma America, Inc.
Revolution Medicines, Inc.
Dana-Farber Cancer Institute
Indiana University
Abramson Cancer Center at Penn Medicine
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Taiho Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
Takeda
Cedars-Sinai Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Texas Southwestern Medical Center
Baylor College of Medicine
Isofol Medical AB
Abramson Cancer Center at Penn Medicine